Viewpoint Molecular Targeting, Inc. reported raising $8.84 Million in an initial SEC Form D filing, from an offering of $15.8 Million
Amount Raised
$8.84 Million
Round Type
Venture
CoralvilleBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as Viewpoint Molecular Targeting, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Cardio Flow, Inc. raised $489K (Seed) on January 15, 2021.
- SAGE Therapeutics raised $650M on January 15, 2021.
- Impulse Dynamics raised $60M on January 15, 2021.
- Gatehouse Bio, Inc. raised $5.4M on January 15, 2021.
- CDI Laboratories, Inc. raised $2.1M (Seed) on January 15, 2021.
- EIP Pharma, Inc. raised $5.1M on January 15, 2021.
Who to call at Viewpoint Molecular Targeting, Inc., and when
A new round usually means Viewpoint Molecular Targeting, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Viewpoint Molecular Targeting, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Viewpoint Molecular Targeting, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Viewpoint Molecular Targeting, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Viewpoint Molecular Targeting, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Viewpoint Molecular Targeting, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.